Image of Rosuvastatin/Ezetimibe: A Review in Hypercholesterolemia

LITERATURE

Rosuvastatin/Ezetimibe: A Review in Hypercholesterolemia


Rosuvastatin/ezetimibe combines two lipid-lowering agents: rosuvastatin, an HMG-CoA reductase inhibitor (i.e. statin)
with particularly strong inhibitory efects on hepatic cholesterol synthesis, and ezetimibe, which inhibits the intestinal
absorption of cholesterol. A fxed-dose combination (FDC) of rosuvastatin/ezetimibe is indicated as an adjunctive therapy
to diet for the management of primary hypercholesterolemia in adults in numerous countries worldwide


Availability

Rosufer-006Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
American Journal of Cardiovascular Drugs
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous